Untitled Reply

Cong Dai

doi:10.14309/ajg.0000000000003556

2025-12-01

PRE

Cong Dai *

Yühong Huang

Min Jiang

DOI：10.14309/ajg.0000000000003556

原文链接

摘要

期刊

American Journal of Gastroenterology

IF:

7.6

论文数:

5.1W

被引数:

3.3W

机构

china medical university

学者数:

4.7K

论文数: 1.5K

被引数: 0

引用论文

Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13)

BMJ OPEN GASTROENTEROLOGY

IF2.9

2023-02-22

OAAI

Carbery, Isabel; Burdge, Gemma; Clark, Tanya; Broglio, Giacomo; Greer, Dan; Alakkari, Alaa; Selinger, Christian Philipp

Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH-LT study

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2023-11-30

PREAI

Buisson, A.; Nachury, M.; Bazoge, M.; Yzet, C.; Wils, P.; Dodel, M.; Coban, D.; Pereira, B.; Fumery, M.

Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure

GUT AND LIVER

IF3.2

2024-06-05

OAAI

Bae, June Hwa; Park, Jung-Bin; Baek, Ji Eun; Hong, Seung Wook; Park, Sang Hyoung; Yang, Dong-Hoon; Ye, Byong Duk; Byeon, Jeong-Sik; Myung, Seung-Jae; Yang, Suk-Kyun; Hwang, Sung Wook